|Day Low/High||269.00 / 278.45|
|52 Wk Low/High||208.07 / 287.94|
I have the answer behind the conundrum that forces stocks up that should be going lower.
These stocks's earnings were 'not as bad as feared,' and here are some more names that pushed the NABAF narrative.
There are plenty of senior growth companies that can still move higher.
The Fed is doing this right. Let me repeat... the Fed is not screwing this up.
As mentioned earlier, breadth was only 2-1 positive with UnitedHealth , JPMorgan and Johnson & Johnson responsible for a large portion of the market's gains. Bond yields rose, aiding the rate-sensitive banks (who generally met expectations). FANG ha...
"Only" about 2-1 advancers over decliners as UnitedHealth Care , JP Morgan and Johnson & Johnson account for a disproportionate amount of the market's rally.
Citigroup and Lululemon are on the radar this morning.
These three CEFs are particularly appealing right now, with overhyped fears making them unusually cheap.
Quintessential investor Graham described the stock market in the short term as an imperfect voting machine.
Let's get the charts and indicators in for a check up.
The impact of Elizabeth Warren is pretty much everywhere Thursday.
What the Fed needs to do in July is to cut the FFR by 25 basis points and put the balance sheet management (QT) program to bed two months early.
And just why do we have a federal debt ceiling, anyway? An argument for doing away with it.
Here are my five rules for handling earnings season.
Schwab, Domino's, Netflix and UnitedHealth are set to report their quarterly results.
But the fear of missing out is keeping a strong bid under the market.
This matters: Why the sudden 'weakness' across European debt markets?
The indices are in good shape technically, although there was choppy and inconsistent action under the surface Thursday.
A look at the charts and indicators of three big names in the sector .
These managed care stocks can withstand China, politics and a slowdown in the economy.
These are the days when if you're brave you get a good price and begin the ride to greater riches.
As CVS Health's stock continues to run, management's careful approach should be encouraging for beleaguered investors.
The fear will subside around health care stocks, and here is why.
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
Insurance companies would have their claws in any potential new healthcare law so deep, the law will have slash marks on it.
Especially when healthcare CEOs discus political issues with analysts and reporters.